Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06682663

Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) is a clinical and pathological syndrome characterized primarily by excessive intracellular fat accumulation in the liver, excluding alcohol-related and other specific causes. Recent research has identified an association between MASLD and an increased risk of pregnancy-related complications and adverse pregnancy outcomes, including gestational diabetes, preeclampsia, preterm birth, and large-for-gestational-age infants. MASLD in pregnant women poses multiple risks to maternal and infant health. Regular physical exercise during pregnancy has been shown to effectively reduce the incidence of pregnancy complications and adverse outcomes, while also alleviating hepatic steatosis and fibrosis. This study is a randomized controlled trial aimed at exploring the feasibility and effectiveness of online exercise interventions for pregnant women with MASLD, as well as conducting a cost-effectiveness analysis and investigating the underlying physiological mechanisms based on the liver-gut axis. The findings are intended to provide scientific evidence and practical recommendations for managing pregnancy health and intervening in MASLD during pregnancy.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Singleton pregnancy;
  • Gestational age ≤10-13+6 weeks at enrollment;
  • Age between 20 and 45 years;
  • Patients diagnosed with MASLD;
  • Signed informed consent.

Exclusion criteria

  • Cervical length ≤ 25 mm;
  • History of threatened abortion;
  • Exercise contraindications or doctor advice not to exercise during pregnancy;
  • Current or previous use of drugs that affect body weight (such as hormones);
  • Patients with chronic hepatitis virus or other chronic liver diseases, excluding MASLD;
  • Non-natural conception or infertility treatment;
  • Any previous medication for hypertension, diabetes, heart disease, kidney disease, systemic lupus erythematosus, thyroid disease or mental illness;
  • Participating in other pregnancy intervention research projects.

Treatment and study plan

Live Streaming Exercise

Behavioral

Participants try to achieve 150 minutes of moderate-vigorous training per week. The exercise program includes live streaming exercise by trained health professionals, including pregnancy-specific exercises, with professional pregnancy trainers to provide guidance and support when needed.

Primary outcomes

  1. Liver steatosis

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    LiSA, by Hepatus, Mindray, China;

  2. Liver stiffness measurement

    Time frame: Changes from the 14th week to 36 weeks +6 days of pregnancy

    E, by Hepatus, Mindray, China

Secondary outcomes

  1. Gestational weight change

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    weight changes in kilograms

  2. Incidence of pregnancy-related complications including gestational diabetes mellitus, gestational hypertension and related diseases

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    All diagnoses according to the guidelines.

  3. Changes in fasting serum lipids(TG, TC, LDL, HDL)

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    All data with the routine health check-up.

  4. Changes in fasting blood glucose

    Time frame: Changes from the 14th week to 36 weeks +6 days of pregnancy

    with the routine check-up

  5. Changes in blood pressure

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    Both systolic and diastolic blood pressure are measured

  6. Changes in alanine aminotransferase (ALT)

    Time frame: Changes from the 14th week to 36 weeks +6 days of pregnancy

  7. Changes in aspartate aminotransferase (AST)

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

  8. Maternal physical activity

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    physical activity, which collected by International Physical Activity Questionnaire Short Form,IPAQ-SF

  9. Maternal sleep quality

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    sleep quality, which collected by Pittsburgh Sleep Quality Questionnaire

  10. Maternal mental health

    Time frame: Changes from the 14th week to 36 weeks + 6 days of pregnancy

    mental health, which collected by Generalized Anxiety Disorder-7 questionnaire, Edinburgh Pregnancy Depression Scale and Patient Health Questionnaire-9 items

  11. Fetal height and weight

    Time frame: fetal data were collected from gestational week 14 to 36 week +6 days, other data collected on the delivery.

    fetal height and weight, measured by ultrasonic, height in cm and weight in kg

  12. Height and weight at birth

    Time frame: fetal data were collected from gestational week 14 to 36 week +6 days, other data collected on the delivery.

    height, weight at birth,height measured with a rangefinder and weight measured with a scale,height in cm and weight in kg

  13. Baby's Apgar Score

    Time frame: fetal data were collected from gestational week 14 to 36 week +6 days, other data collected on the delivery.

    Apgar score,measured by clinical diagnosis

  14. Preterm birth

    Time frame: fetal data were collected from gestational week 14 to 36 week +6 days, other data collected on the delivery.

    preterm birth,clinical diagnosis

  15. Small gestational week

    Time frame: fetal data were collected from gestational week 14 to 36 week +6 days, other data collected on the delivery.

    small gestational week,clinical diagnosis

  16. Large gestational week

    Time frame: fetal data were collected from gestational week 14 to 36 week +6 days, other data collected on the delivery.

    large gestational week,clinical diagnosis

Study contacts

Contact information is provided by the study sponsor or research team.

Hui Wang, Ph.D

CONTACT

[email protected]

19800363805

Mingyue Wang, MD

CONTACT

[email protected]

19862183196

Sponsors and collaborators

Lead sponsor

Peking University

Other

Collaborators

  • Beijing Friendship Hospital
  • W.F. Maternal and Child Health Hospital

Registry information

Official study title

Evaluation of the Effect of Live Streaming Exercise on the Improvement of Hepatic Steatosis and Fibrosis in Pregnant Women with MASLD and Its Study Based on the Liver-gut Axis Mechanism.

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Nov 12, 2024
Registry last updated
Nov 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.